Guangjun Liu

Xuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Lactylation-Mediated METTL14 Promotes Glycolysis Through Facilitating PGAM1 m6A Methylation in Non-Small Cell Lung Cancer.

Lactylation-Mediated METTL14 Promotes Glycolysis Through Facilitating PGAM1 m6A Methylation in Non-Small Cell Lung Cancer.

Journal: Immunological investigations

Published: April 23, 2026

Dietitian-led individualized pancreatic enzyme replacement therapy is associated with favorable nutritional and immune-inflammatory profiles in pancreatic cancer: a retrospective cohort study.

Dietitian-led individualized pancreatic enzyme replacement therapy is associated with favorable nutritional and immune-inflammatory profiles in pancreatic cancer: a retrospective cohort study.

Journal: Frontiers in nutrition

Published: August 10, 2025

The tRF-3024b hijacks miR-192-5p to increase BCL-2-mediated resistance to cytotoxic T lymphocytes in Esophageal Squamous Cell Carcinoma.

The tRF-3024b hijacks miR-192-5p to increase BCL-2-mediated resistance to cytotoxic T lymphocytes in Esophageal Squamous Cell Carcinoma.

Journal: International immunopharmacology

Published: June 25, 2023

High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.

High-risk histological subtype-related FAM83A hijacked FOXM1 transcriptional regulation to promote malignant progression in lung adenocarcinoma.

Journal: PeerJ

Published: May 26, 2023

Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma.

Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: May 16, 2023

Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China.

Cost-Effectiveness of Tislelizumab Versus Docetaxel for Previously Treated Advanced Non-Small-Cell Lung Cancer in China.

Journal: Frontiers in pharmacology

Published: December 07, 2021

Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China.

Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China.

Journal: Advances in therapy

Published: May 24, 2021

Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity.

Chr1 95026203-ALK, a novel intergenic fusion identified in a patient with lung adenocarcinoma with nodular ground-glass opacity.

Journal: Journal of thoracic disease

Published: April 19, 2021

Beta amyloid-induced time-dependent learning and memory impairment: involvement of HPA axis dysfunction.

Beta amyloid-induced time-dependent learning and memory impairment: involvement of HPA axis dysfunction.

Journal: Metabolic brain disease

Published: January 21, 2020

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis.

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis.

Journal: Medicine

Published: October 01, 2019

Tirofiban for acute ischemic stroke: systematic review and meta-analysis.

Tirofiban for acute ischemic stroke: systematic review and meta-analysis.

Journal: European journal of clinical pharmacology

Published: August 25, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026